Not only is it life or death situation when it comes down to fighting cancer, the earlier you can find out, the earlier you ...

Itovebi — also known as inavolisib — is designed to be given with drugs from Pfizer Inc. and AstraZeneca plc to treat adults ...

The title of the poster presentation for the Phase 1/2a study of [ 212 Pb]VMT01 is “First in Human Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Melanoma (MM).” “We are looking forward ...

A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General ...

The Seattle oncologist spoke at Gonzaga University on Wednesday, delivering a presentation titled “How Close Are We to a ...

Seven out of 67 children who were given bluebird's (BLUE) gene therapy Skysona during clinical trials ended up developing ...

The approval of inavolisib is supported by findings from the phase 3 INAVO120 study evaluating the agent plus palbociclib and ...

Lesia shares her story as a breast cancer survivor: from being diagnosed in her early thirties to thriving cancer-free for ...

A daily dose of turmeric may offer health benefits for women specific to the female reproductive organs, such as PCOS. Find ...

Northwestern Medicine investigators have discovered that a novel combination therapy promotes cancer cell death and tumor ...

A borderland cancer survivor shares her story to hopefully inspire women during Breast Cancer Awareness Month.